Takimoto, Eiki
Compartmentalization of cardiac beta-adrenergic inotropy modulation by phosphodiesterase type 5. [electronic resource]
- Circulation Apr 2007
- 2159-67 p. digital
Publication Type: Comparative Study; Journal Article; Research Support, N.I.H., Extramural; Research Support, Non-U.S. Gov't
ISSN: 1524-4539
Standard No.: 10.1161/CIRCULATIONAHA.106.643536 doi
Subjects--Topical Terms: 3',5'-Cyclic-GMP Phosphodiesterases--antagonists & inhibitors Animals Atrial Natriuretic Factor--pharmacology Cell Compartmentation--physiology Cell Membrane--enzymology Cells, Cultured--drug effects Cyclic GMP--physiology Cyclic GMP-Dependent Protein Kinases--antagonists & inhibitors Cyclic Nucleotide Phosphodiesterases, Type 5 Cytosol--enzymology Enzyme Activation--drug effects Guanylate Cyclase--metabolism Isoproterenol--pharmacology Male Mice Mice, Inbred C57BL Myocardial Contraction--drug effects Myocytes, Cardiac--drug effects NG-Nitroarginine Methyl Ester--pharmacology Nitric Oxide--physiology Phosphodiesterase Inhibitors--pharmacology Piperazines--pharmacology Protein Kinase Inhibitors--pharmacology Purines--pharmacology Receptors, Adrenergic, beta--drug effects Second Messenger Systems--physiology Sildenafil Citrate Sulfones--pharmacology